References
- Streit M, Bregenzer T, Heinzer I. Cutaneous infections due to atypical mycobacteria. Der Hautarzt 2008; 59: 59–70
- Aubry A, Chosidow O, Caumes E, Robert J, Cambau E. 63 cases of Mycobacterium marinum infection. Arch Intern Med 2002; 162: 1746–52
- Jernigan JA, Farr BM. Incubation period and sources of exposure for cutaneous Mycobacterium marinum infection: case report and review of the literature. Clin Infect Dis 2000; 31: 439–43
- Iredell J, Whitby M, Blacklock Z. Mycobacterium marinum infection: epidemiology and presentation in Queensland 1971–1990. Med J Aust 1992; 157: 596–8
- Edelstein H. Mycobacterium marinum skin infections: report of 31 cases and review of the literature. Arch Intern Med 1994; 154: 1359–64
- Dodiuk-Gad R, Dyachenko P, Ziv M, Shani-Adir A, Oren Y, Mendelovici S, et al. Non-tuberculous mycobacterial infections of the skin: a retrospective study of 25 cases. J Am Acad Dermatol 2007; 57: 413–20
- Streit M, Böhlen LM, Hunziker T, Zimmerli S, Tscharner GG, Nievergelt H, et al. Disseminated Mycobacterium marinum infection with extensive cutaneous eruption and bacteraemia in an immunocompromized patient. Eur J Dermatol 2006; 16: 79–83
- Jogi R, Tyring S. Therapy of non-tuberculous mycobacterial infections. Dermatol Ther 2004; 17: 491–8
- Weitzul S, Eichhorn PJ, Pandya AG. Non-tuberculous mycobacterial infections of the skin. Dermatol Clin 2000; 18: 359–77
- Wallace RJ, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1992; 166: 405–12
- Brown BA, Wallace RJ, Onyi GO, de Rosas V, Wallace RJ. Activities of 4 macrolides, including clarithromycin, against Mycobacterium fortitium, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother 1992; 36: 180–4